Lonza Presents: Develop the Best Formulation for Your New MoleculeEvent-Datum: 13.10.2022
Parenteral Drug Product: formulation development, capability, and strategy
Join us for the face-to-face event and meet our experts
Lonza’s Parenteral Drug Product Services has been experiencing fast growth over the last years and today provides fully integrated, phase-appropriate solutions to drug product development and manufacturing addressing formulation, process design, and primary packaging. This approach can help to differentiate your product and support your products lifecycle management. This presentation offers you a short but comprehensive overview of our offering.
- “Lonza Drug Product Services – capabilities and strategy” by Reto Renggli, Director, Commercial Development, Drug Product Services
This presentation introduces the key capabilities of Lonza Drug Product Services. It offers an overview of the current assets and overall set-up and, in addition, puts a spotlight on future growth initiatives.
- “Better earlier than later: formulation development” by Razvi Abbas, Senior Director, Pharmaceutical Development, Drug Product Services
Sound Pharmaceutical development is key to the success of development programs. However, speed to the clinic is key to keeping the program competitive overall. Here we will present to you key offerings from Lonza DPS to enable a fast entry to the clinic for various molecular modalities while balancing the risk and ensuring the overall success of clinical programs.